FDA chief Gottlieb ‘names and shames’ big pharma for delaying generic competition
When Dr. Scott Gottlieb, commissioner of the Food and Drug Administration, publicly listed pharmaceutical companies that have “potentially blocked access” to samples of their branded products to generic drug developers —...
Subscription required to view this article.
This content can only be accessed by FTCWatch subscribers. If you are an FTCWatch subscriber, please login to access this content